THE EMMES COMPANY, LLC
ROCKVILLE, Maryland
Total Received
$671.8M
Total Awards
121
State
Maryland
Last Updated
Apr 1, 2026
Yearly Funding Trend
$590.7M24
$78.2M25
$2.9M26
Top 50 Awards to THE EMMES COMPANY, LLC
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through April 1, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_75N93021C00012_7529_-NONE-_-NONE- SDCC | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $169,199,509 |
CONT_AWD_HHSN272201500002C_7529_-NONE-_-NONE- (SDCC) | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $100,191,274 |
CONT_AWD_HHSN275201700002C_7529_-NONE-_-NONE- DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $55,340,350 |
CONT_AWD_75N91019C00008_7529_-NONE-_-NONE- LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INSTITUTIONAL REVIEW BOARD (CIRB) | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $37,255,012 |
CONT_AWD_75N91021C00009_7529_-NONE-_-NONE- CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $35,670,608 |
CONT_AWD_HHSN263201700001C_7529_-NONE-_-NONE- FY 19 EXPIRING LINES | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $35,391,880 |
CONT_AWD_75N98022C00001_7529_-NONE-_-NONE- THE EMMES COMPANY | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $25,477,032 |
CONT_AWD_HHSN261201600002C_7529_-NONE-_-NONE- CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $24,364,181 |
CONT_AWD_HHSN271201400028C_7529_-NONE-_-NONE- DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT FOR NIDA (DSC4). POP: JUNE 19, 2014-JULY 20, 2024. N01DA-14-2237. | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $21,198,766 |
CONT_AWD_75N91024C00024_7529_-NONE-_-NONE- LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $18,014,450 |
CONT_AWD_HHSN26800003_7529_HHSN268201400002I_7529 THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC) | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $13,756,583 |
CONT_AWD_75N93020C00002_7529_-NONE-_-NONE- EXERCISE OPTION 6 | Department of Health and Human Services National Institutes of Health | — | BETHESDA, MD-08 | 2024 | $11,597,296 |
CONT_AWD_75N95023C00013_7529_-NONE-_-NONE- DATA COORDINATING CENTER (DCC) TO WORK COLLABORATIVELY WITH THE NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) CLINICAL SITES FOR NIMH | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $9,540,417 |
CONT_AWD_75N95022C00041_7529_-NONE-_-NONE- NINDS CENTER FOR CLINICAL TRIAL RESOURCES | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $7,528,164 |
ASST_NON_OT2HL142340_075 SICKLE CELL DISEASE CURE INITIATIVE (SCDC) | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | ROCKVILLE, MD-08 | 2024 | $7,000,926 |
CONT_AWD_HHSN271201700064C_7529_-NONE-_-NONE- TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF T… | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $6,972,902 |
CONT_AWD_HHSN272201500001C_7529_-NONE-_-NONE- VACCINE RESEARCH CENTER (VRC) CLINICAL TRIALS PROGRAM (CTP) DATA MANAGEMENT | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $6,689,651 |
CONT_AWD_75N95023F00001_7529_75N95020D00012_7529 TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN) HEAL STUDIES. | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $4,951,204 |
CONT_AWD_HHSN268201600020C_7529_-NONE-_-NONE- PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT III) COORDINATING CENTER (CC) | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $4,756,253 |
CONT_AWD_75N95025F00001_7529_75N95024D00037_7529 TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29 | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $4,656,081 |
CONT_AWD_75N98022F00001_7529_75N98022D00012_7529 EMMES CORP:1108738 [22-001337] | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $4,027,835 |
CONT_AWD_75N95020F00001_7529_75N95020D00012_7529 CTN CLINICAL COORDINATING CENTER SUPPORT; POP 08/14/20-08/13/21 | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $3,744,212 |
CONT_AWD_75N95024F00001_7529_75N95024D00037_7529 CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CTN PORTFOLIO SUPPORT (NON-HEAL). 8/15/24 - 8/14/25 | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $3,651,969 |
CONT_AWD_75N95024F00003_7529_75N95024D00037_7529 CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15… | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $3,419,274 |
CONT_AWD_75N95024F00002_7529_75N95024D00037_7529 CTN HEAL ENHANCEMENT. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. TO2. POP: 8/15/24 - 11/1/2026 | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $2,988,430 |
CONT_AWD_75N95020F00002_7529_75N95020D00012_7529 CTN CLINICAL COORDINATING CENTER - HEAL STUDIES. POP: 8/14/20-6/15/21 | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $2,938,848 |
CONT_AWD_75N95020F00001_7529_75N95019D00013_7529 NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2020 - 02/28/2021. N01DA-19-2250. TASK ORDER 75N95020F00001 (TO12). | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $2,645,396 |
ASST_NON_U01DK133709_075 CONTINUATION OF THE COLLABORATIVE ISLET TRANSPLANTATION REGISTRY (CITR) - PROJECT SUMMARY THIS APPLICATION, IN RESPONSE TO RFA-DK-21-013, DESCRIBES A COMPREHENSIVE DATA AND STATIS… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | MD-90 | 2024 | $2,399,074 |
CONT_AWD_75N95022F00002_7529_75N95022D00017_7529 INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 09/30/2027. DSC6. 75N95022F0000… | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $2,067,729 |
CONT_AWD_75N95024F00001_7529_75N95020D00012_7529 TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN) HEAL STUDIES. POP 2/26/24 -… | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $2,026,076 |
ASST_NON_UG1EY028517_075 PHASE I/II RANDOMIZED, PROSPECTIVE, DOUBLE-BLINDED, SHAM-CONTROLLED CROSS-OVER STUDY OF INTRAVITREAL AUTOLOGOUS BONE MARROW CD34+ STEM CELL THERAPY FOR RETINAL VEIN OCCLUSION - PR… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | MD-90 | 2024 | $1,938,740 |
CONT_AWD_75N95022F00004_7529_75N95022D00017_7529 KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 03/31/2027. DSC6. 75N95022F00004 (TO4). | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $1,900,771 |
CONT_AWD_75N95022F00003_7529_75N95022D00017_7529 OFFICE-BASED METHADONE VS BUPRENORPHINE TO ADDRESS RETENTION IN MEDICATION FOR OPIOID USE DISORDER (MOUD)-A PRAGMATIC HYBRID EFFECTIVENESS/IMPLEMENTATION TRIAL (CTN-013). 09/28/20… | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,861,518 |
CONT_AWD_75N95025F00001_7529_75N95022D00017_7529 DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25). | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $1,848,496 |
CONT_AWD_75N95024F00002_7529_75N95022D00017_7529 DSC MANAGEMENT AND SUPPORT. FEBRUARY 29, 2024 - FEBRUARY 28, 2025. N01DA-22-2253. TASK ORDER NO. 75N95024F00002 (TO18). | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,804,120 |
CONT_AWD_75N95025F00002_7529_75N95024D00037_7529 TO5. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29 | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $1,707,498 |
CONT_AWD_HHSN27200002_7529_HHSN272201000049I_7529 RECOVERY: VRC UNIV FLU UIGCPSC | Department of Health and Human Services National Institutes of Health | — | BETHESDA, MD-08 | 2024 | $1,645,559 |
CONT_AWD_75N95024F00007_7529_75N95022D00017_7529 OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO.… | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,510,879 |
CONT_AWD_75N95021F00004_7529_75N95019D00013_7529 NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 07/01/2021 - 9/30/2024. N01DA-19-2250. TASK ORDER 75N95021F00004 (TO23). | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,406,983 |
CONT_AWD_75N95025F00002_7529_75N95022D00017_7529 DATA AND STATISTICAL ANALYSIS FOR GLP-1 AS AN ADJUNCT TO BUPRENORPHINE. MAY 21, 2025 - FEBRUARY 29, 2028. N01DA-22-2253. TASK ORDER NO. 75N95025F00002 (TO26). | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $1,397,875 |
CONT_AWD_75N94023F00001_7529_75N94018D00006_7529 DATA COORDINATING CENTER FOR THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES: FOLLOW-UP OF THE FIRST SUBCOHORT AND INITIATION OF RECRUITMENT OF THE SECOND SUBCOHORT OF… | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,342,599 |
CONT_AWD_HHSN27500004_7529_HHSN275201300026I_7529 DATA COORDINATING CENTER FOR UPSTATE KIDS CVD FOLLOW-UP STUDY | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,308,510 |
CONT_AWD_75N95022F00003_7529_75N95020D00012_7529 MANAGEMENT OF UNHEALTHY OPIOID AND POLYSUBSTANCE USE AMONG PATIENTS IN PRIMARY CARE SETTINGS. FY22. POP 9/15/22 - 9/14/27. | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,299,926 |
CONT_AWD_75N95021F00003_7529_75N95019D00013_7529 NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 07/01/2021 - 02/28/2025. N01DA-19-2250. TASK ORDER 75N95021F00003 (TO22). | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,154,351 |
ASST_NON_OT2HL146019_075 SUPPORT SERVICES FOR THE NHLBI-SPONSORED DATA SCIENCE INSTITUTIONAL REVIEW BOARD - THIS PROPOSAL TO SERVE AS THE SUPPORT SERVICES FOR THE NHLBI-SPONSORED DATA SCIENCE INSTITUTIONA… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MD-90 | 2026 | $1,100,076 |
CONT_AWD_75N95024F00002_7529_75N95020D00012_7529 FY24. TASK ORDER 14. CTN CLINICAL COORDINATING CENTER, POP: 5/15/2024-8/25/2024 | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,063,442 |
CONT_AWD_75N95023F00004_7529_75N95020D00012_7529 CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27. | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $1,036,687 |
CONT_AWD_75N95023F00004_7529_75N95022D00017_7529 BETTER TOGETHER: INTEGRATING MOUD IN AFRICAN AMERICAN COMMUNITY SETTINGS. SEPTEMBER 15, 2023 TO AUGUST 31, 2026. N01DA-22-2253. TASK ORDER 75N95023F00004 (TO8). | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2026 | $999,995 |
CONT_AWD_75N98019F00848_7529_HHSN263201600022I_7529 FY 19 EXPIRING LINES EMMES CORP:1108738 [19-004300] | Department of Health and Human Services National Institutes of Health | — | BETHESDA, MD-08 | 2024 | $810,664 |
CONT_AWD_75N95020F00007_7529_75N95019D00013_7529 TRANSCRANIAL MAGNETIC STIMULATION FOR THE TREATMENT OF METHAMPHETAMINE/COCAINE USE DISORDER (CTN-0108). 9/21/2020-7/17/2023. N01DA-19-2250. TASK ORDER 75N95020F00007 (TO18). | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2025 | $806,041 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Funding Agencies
View All→Industries
View All→123456789
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)$184.8M
RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY$169.2M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$98.7M
ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES$96.0M
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY$55.6M
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES$26.0M
CUSTOM COMPUTER PROGRAMMING SERVICES$18.3M
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$7.8M
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES$3.0M
Source: USAspending.gov · All Recipients · Maryland